CN Stock MarketDetailed Quotes

Hangzhou Tianmushan Pharmaceutical Enterprise (600671)

Watchlist
  • 19.30
  • +0.24+1.26%
Market Closed May 19 15:00 CST
2.35BMarket Cap144.03P/E (TTM)

Hangzhou Tianmushan Pharmaceutical Enterprise (600671) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drug circulation50.35M23.78%
Iron maple bucket40.13M18.95%
Other28.8M13.60%
Menthol brain26.34M12.44%
六味地黄口服液(无糖型)22.41M10.58%
参类12.7M6.00%
Cordyceps sinensis11.42M5.39%
酒系列8.41M3.97%
康源软胶囊6M2.83%
Training5.19M2.45%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Health products90.99M42.97%
流通商品50.35M23.78%
Raw material medicine30.3M14.31%
Chinese patent medicine28.26M13.35%
Service class5.19M2.45%
medical apparatus3.79M1.79%
Chemical drugs1.84M0.87%
Other979.71K0.46%
Other business57.55K0.03%
View all

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region195.2M92.18%
South China5.96M2.81%
Southwest area5.38M2.54%
Central China3.17M1.50%
Northeast area894.56K0.42%
North China807.47K0.38%
Northwest region274.93K0.13%
Other business57.55K0.03%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More